Acquired by New Relic.
.png)
Obulytix develops the next generation of enzyme-based antibiotics inspired by nature.
moveUP develops personalized remote digital care for patients undergoing surgery and other interventions.
Animab develops antibodies to tackle gastrointestinal pathogens in livestock.
